Dr. Chapa’s Clinical Pearls.  cover image

The 39 Week IOL “Dilemma”

Dr. Chapa’s Clinical Pearls.

00:00

The Validity of the Arrived Trial

The arrived trial was the first large scale RCT showing benefit to elective induction of labra 39 weeks. Other studies have shown similar benefits, but there may be more benefit as the patient gets older. The ACOG of Surgical Consensus Number 11 found that a risk model still exists in women aged 40 to 44 at 39 weeks and up.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app